News

Microbix is transferring all of its influenza vaccine assets into Crucible, along with an exclusive worldwide license to its Virusmax technology, and the company’s 50% ownership interest in

During the conference – ‘Rare neurological diseases of childhood,’ the participants endorsed a ‘Declaration of Principles’ launching a new initiative to increase research into rare neurological diseases and

The collaboration combines GE Healthcare’s global presence and expertise in biopharmaceutical manufacturing technology with G-Con’s modular portable flexible clean-room technology. The collaboration will offer comprehensive GMP manufacturing solutions

APR said Zolmitriptan ODF is a very thin polymeric film strip with a size of 3sqcm and 6sqcm for the 2,5mg and 5mg dosage strengths, respectively. Zolmitriptan ODF

The compound targets AD via selective butyrylcholinesterase inhibition (BChEI) as well as with a disease modifying activity via amyloid precursor protein (APP) inhibition. QR Pharma has completed all

Using A5 Labs production technology, it is anticipated that approximately 2,000 doses of the VI-1718 will be manufactured with certificates of analysis in the next 4 weeks. A5

CTI had requested accelerated approval of its Pixantrone NDA for a patient group for which there are no drugs currently approved in this clinical setting. The Office of

The patents cover the Momenta Pharma’s methods of producing Enoxaparin sodium, which assure that the commercial product meets standards for identity and quality. One patent, US Patent no.

The double- blind, single ascending dose study was conducted in 16 young healthy human volunteers, with 12 receiving ascending doses of GLPG0492 (ranging 0.5 to 120mg) and four